| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.89B | +39.1% |
| Cost of Revenue | $16.04B | +43.2% |
| Gross Profit | $12.86B | +34.3% |
| R&D Expense | $2.27B | +17.3% |
| SG&A Expense | $1.08B | +11.9% |
| Operating Income | $3.20B | +21.7% |
| Pre-tax Income | $2.84B | +16.9% |
| Income Tax | $845.0M | +62.2% |
| Net Income | $2.00B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.67B | +39.3% |
| Short-term Investments | $2.63B | -41.4% |
| Accounts Receivable | $369.0M | +44.7% |
| Inventory | $570.0M | +92.6% |
| Current Assets | $33.57B | +66.7% |
| Total Assets | $42.67B | +69.3% |
| Current Liabilities | $28.63B | +72.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.12B | +53.0% |
| Investing Cash Flow | -$6.18B | +25.4% |
| Financing Cash Flow | $2.90B | +48.2% |
| +4.5% |
| EPS (Basic) | $39.40 | +4.5% |
| EPS (Diluted) | $39.40 | +4.5% |
| Long-term Debt |
| $9.19B |
| +60.9% |
| Total Liabilities | $35.92B | +72.3% |
| Stockholders' Equity | $6.75B | +55.1% |